FDA extends regulatory reach to low-risk CDS software The agency expands its overview of products to now include those that support or provide a recommendation to clinicians. Bradley Merrill Thompson • Mar 2, 2018 • Policy
How the FDA could impact machine learning, IoT in healthcare Focus on reducing regulations may rachet down pressure on developers and trim costs for testing. Bradley Merrill Thompson • May 18, 2017 • AI